7 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
anticoagulants (DOACs ... anticoagulant; LMWH ... body mass index; VTE ... #DOAC #VTE #Malignancy ... Anticoagulation #Management
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
algorithm for VTE ... thrombosis in cancer ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... Anticoagulation #Management
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
the mainstay of VTE ... . heparin, LMWH, ... anticoagulant (e.g ... #UFH #DOAC #Dabigatran ... #Fondaparinux #NOAC
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup and Management ... Echinocandins (e.g ... Generally no routine TTE ... unless clinical concern ... IDSA #Guidelines #Management
Duration of Treatment of Venous Thromboembolism (VTE)
 - Major transient risk factor (eg, major surgery, major
Thromboembolism (VTE ... transient risk factor (eg ... or as long as cancer ... Indefinite #VTE ... Thromboembolism #Management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Management during ... Avoid Warfarin and DOAC ... Management during ... Management during ... Serial TTE and close
Algorithm for the diagnosis and management of iliofemoral deep vein thrombosis (DVT). In the absence of
diagnosis and management ... CAT = cancer-associated ... inferior vena cava, LMWH ... #dvt #vte #thromboembolism